Physician profile
Michael Briscoe
NPI 1205030806
$4,366.84
in general payments reported to CMS, 2019-2025
19 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.98 · 2022: $951 · 2023: $1,241 · 2024: $1,046 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,395 · Travel and Lodging: $3.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,394.57 |
| Travel and Lodging | $3.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $788.03 | 2022 | |
| Aerin Medical INC. | $654.43 | 2022-2024 | |
| Glaxosmithkline, LLC. | $640.24 | 2022-2025 | Nucala |
| Medtronic, INC. | $424.94 | 2023-2025 | Propel, Fusion, Sinuva |
| Genzyme Corporation | $355.69 | 2022-2025 | |
| Optinose US, INC. | $339.52 | 2022-2025 | |
| Hologic Sales and Service, LLC | $315.67 | 2024-2025 | Coolseal Generator |
| Neurent Medical Limited | $285.73 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Acclarent, INC | $154.04 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus |
| Hikma Pharmaceuticals USA | $104.02 | 2023-2024 | Ryaltris |
| Regeneron Healthcare Solutions, INC. | $103.11 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $45.42 | 2025 | Inspire |
| Agiliti Surgical, INC. | $35.47 | 2024 | Bluelight Lasers, Koelis Trinity Fusion Biopsy System, Acupulse Duo Co2 Laser |
| Ars Pharmaceuticals Operations, INC. | $26.40 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $22.73 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.67 | 2025 | Zepbound |
| Olympus America INC. | $18.85 | 2024 | |
| Resmed Corp | $18.29 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $13.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Briscoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.